Praxis Dietikon

Löwenstrasse 15
CH-8953 Dietikon
Fon: +41 44 556 77 06
Fax: +41 44 554 63 03
E-Mail: info@dr-cengic.ch

Praxis Meilen

Im Dörfli 18

CH-8706 Meilen

Fon: +41 44 422 77 06

Fax: +41 44 422 77 05
E-Mail: info@dr-cengic.ch



Öffnungszeiten

Dienstag bis Samstag

MI.: 08.30-13.00 15.00-20.00
SA.: 08.00-14.00

Dr. med. (BIH) Neziha Cengic
Fachärztin FMH für Gynäkologie & Geburtshilfe

Öffnungszeiten

Dienstag bis Samstag

DI.: 08.30-13.00   13.30-16.30
DO.: 08.00-13.00   13.30-16.30
FR.: 08.00-13.00 15.00-20.00

Publikationsliste

 

1: Willhauck MJ, Sharif Samani BR, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Göke B, Morris JC, Spitzweg C.

alpha-Fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.

Gene Ther. 2007 Nov 8; [Epub ahead of print]

PMID: 17989705 [PubMed - as supplied by publisher]


2:
Unterholzner S, Willhauck MJ, Cengic N, Schütz M, Göke B, Morris JC,SpitzwegC.

Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells.

J Clin Endocrinol Metab. 2006 Jan;91(1):69-78. Epub 2005 Oct 18.

PMID: 16234306 [PubMed - indexed for MEDLINE]


3:
Cengic N, Baker CH, Schütz M, Göke B, Morris JC, Spitzweg C.

A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.

J Clin Endocrinol Metab. 2005 Aug;90(8):4457-64. Epub 2005 Jun 7.

PMID: 15941870 [PubMed - indexed for MEDLINE]


4:
Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Göke B, Morris JC, Spitzweg C.

Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.

Gene Ther. 2005 Feb;12(3):272-80.

PMID: 15510175 [PubMed - indexed for MEDLINE]


5:
Auernhammer CJ, Kopp FB, Vlotides G, Dorn F, Isele NB, Spöttl G, Cengic N, Weber MM, Senaldi G, Engelhardt D.

Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?

Neuroimmunomodulation. 2004;11(4):224-32.

PMID: 15249728 [PubMed - indexed for MEDLINE]


6:
Vlotides G, Sörensen AS, Kopp F, Zitzmann K, Cengic N, Brand S, Zachoval R, Auernhammer CJ.

SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA.

Biochem Biophys Res Commun. 2004 Jul 30;320(3):1007-14.

PMID: 15240148 [PubMed - indexed for MEDLINE]


7:
Auernhammer CJ, Dorn F, Vlotides G, Hengge S, Kopp FB, Spoettl G, Cengic N, Engelhardt D, Weber MM.

The oncostatin M receptor/gp130 ligand murine oncostatin M induces apoptosis in adrenocortical Y-1 tumor cells.

J Endocrinol. 2004 Mar;180(3):479-86.

PMID: 15012602 [PubMed - indexed for MEDLINE]

 

8:Scholz IV, Cengic N, Göke B, Morris JC, Spitzweg C.

Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter.

J Clin Endocrinol Metab. 2004 Mar;89(3):1108-16.

PMID: 15001595 [PubMed - indexed for MEDLINE


9:
Auernhammer CJ, Isele NB, Kopp FB, Spoettl G, Cengic N, Weber MM, Senaldi G, Engelhardt D.

Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3.

Endocrinology. 2003 Apr;144(4):1202-10.

PMID: 12639901 [PubMed - indexed for MEDLINE]

22354dd5f716e31eb94fc0cfad739480.jpg